• OPEN AN ACCOUNT
Indian Indices
Sensex
83,382.71 -244.98
( -0.29%)
Global Indices
Nasdaq
49,156.99 -56.01
(-0.11%)
Dow Jones
6,945.95 -38.79
(-0.56%)
Hang Seng
53,810.56 -530.67
(-0.98%)
Nikkei 225
10,167.22 29.87
(0.29%)
Forex
USD-INR
90.25 0.03
(0.03%)
EUR-INR
105.19 0.24
(0.23%)
GBP-INR
121.43 0.56
(0.46%)
JPY-INR
0.57 0.00
(-0.55%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
610.0166926
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
24.99
28896.63
EPS(TTM)
Face Value()
Div & Yield %
70.19
1
1.03
 

Ajmera Realty & Infra India approves stock split of 1-into-5
Nov 06,2025
The board of  Ajmera Realty & Infra India at its meeting held on 06 November 2025 has approved Sub-division / Split of the existing 1 (One) Equity share of the Company having face value of Rs. 10/- (Rupees Ten only) each fully paid-up, into 5 (Five) Equity shares having face value of Rs. 2/ (Rupees Two only) each, fully paid-up and consequent alteration of Capital Clause of the Memorandum of Association of the Company, subject to approval of the Shareholders and any regulatory/statutory approvals, as may be required under applicable laws.